Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse
- 11 December 2003
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 18 (2) , 293-302
- https://doi.org/10.1038/sj.leu.2403243
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trialBritish Journal of Haematology, 1998
- Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trialThe Lancet, 1998
- Long-term survival after chemotherapy for acute myeloid leukemiaCancer, 1997
- Long-term survival of patients with acute myeloid leukemiaCancer, 1997
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Long-term survival in acute myelogenous leukemiaCancer Genetics and Cytogenetics, 1994
- Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AMLCancer Genetics and Cytogenetics, 1992
- Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 casesBritish Journal of Haematology, 1989
- The clinical significance of karyotype in acute myelogenous leukemiaCancer Genetics and Cytogenetics, 1989
- Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemiasCancer Genetics and Cytogenetics, 1987